REGENXBIO (RGNX) Stock: Buy, Sell, or Hold?
RGNX - REGENXBIO Inc.
$7.43
0.01 (0.13%)
▲
5d:
+0.41%
30d:
-22.6%
90d:
-49.9%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When RGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RGNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RGNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RGNX is currently trading at $7.43, which is considered oversold relative to its 30-day fair value range of $7.65 to $9.17.
Technical Outlook: Technically, RGNX is in a downtrend. Immediate support is located at $7.12, while resistance sits at $8.31.
Market Sentiment: RGNX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $23.73 (+219.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RGNX is in a downtrend. Immediate support is located at $7.12, while resistance sits at $8.31.
Market Sentiment: RGNX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $23.73 (+219.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.65 -
$9.17
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 219.3% below Wall St target ($23.73)
- CAUTION: Bottoming setup, but lagging the sector by 33% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$7.65 -
$9.17
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$7.12
Resistance Level
$8.31
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.47
Wall Street Target
$23.73
(+219.3%)
Revenue Growth (YoY)
405.7%
Profit Margin
-112.6%
Share & Embed Analysis
Last updated: October 03, 2026 1:18 PM ET
Data refreshes hourly during market hours. Next update: 2:18 PM
Data refreshes hourly during market hours. Next update: 2:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 49 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 56 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$310 | 66 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$63 | 60 BUY |
